Tag: Centers for Disease Control and Prevention

People who get injured from COVID-19 vaccines could have a hard time getting compensated

Tina Marie (Ms. Cat)

People who get injured from COVID-19 vaccines could have a hard time getting compensated

Not only does CICP deny compensation for pain and suffering and attorney’s fees, and the right to appeals, it prohibits litigants from holding hearings and introducing evidence and expert testimony. Another CICP disadvantage, Pop said, is that the only the government’s own expert can form the basis for what constitutes a permissible claim. Therefore, he said, under the CICP program, it seems highly unlikely that any individual with a reaction that’s not “open and notorious, even though rare,” could ever get any kind of compensation.

Long-Term-Care Residents and Health Workers Should Get Vaccine First, C.D.C. Panel Says

Tina Marie (Ms. Cat)

Long-Term-Care Residents and Health Workers Should Get Vaccine First, C.D.C. Panel Says

The only member of the committee to vote against the recommendation was Dr. Helen Talbot, an infectious-disease specialist at Vanderbilt University, who expressed discomfort with putting long-term-care residents in the first priority group because the vaccines’ safety had not been studied in that particular population. “We enter this realm of ‘we hope it works and we hope it’s safe,’ and that concerns me on many levels,” she said before the vote.

Highly recommended YouTube video:

Great Reset is Not Communism it is Neofeudalism via Resource and Individual Extractivism

H/T: Churchdog42 on YouTube

Covid-19 Likely in U.S. in Mid-December 2019, CDC Scientists Report

Tina Marie (Ms. Cat)

Covid-19 Likely in U.S. in Mid-December 2019, CDC Scientists Report

In analyzing the blood samples, the CDC scientists found antibodies in 39 samples from California, Oregon and Washington state collected between Dec. 13 and Dec. 16.

The findings suggest there were isolated cases of coronavirus infection on the U.S. West Coast in mid-December, the scientists wrote.

They also found 67 samples with antibodies in Massachusetts, Michigan, Wisconsin or Iowa, and Connecticut or Rhode Island collected between Dec. 30 and Jan. 17.

Research:

Serologic testing of U.S. blood donations to identify SARS-CoV-2-reactive antibodies: December 2019-January 2020

Emergency approval of coronavirus vaccines is not guaranteed, FDA commissioner says

Tina Marie (Ms. Cat)

Emergency approval of coronavirus vaccines is not guaranteed, FDA commissioner says

Career scientists at the FDA are reviewing raw data from the Pfizer and Moderna trials for the first time, investigating any adverse events or side effects that transpired over the course of the trials, different levels of effectiveness among populations and age groups, and whether individuals who were already infected by the coronavirus might have had any unexpected reactions to the vaccine doses.

Hahn said they will also be looking for evidence that the vaccines lead to increased respiratory infections – a concern with vaccines produced for other coronaviruses, such as SARS and MERS – and whether the use of a relatively new method of vaccine development, known as messenger RNA technology, poses any significant risks.